Search Results
Search for other papers by Athanasios Bikas in
Google Scholar
PubMed
Search for other papers by Kirk Jensen in
Google Scholar
PubMed
Search for other papers by Aneeta Patel in
Google Scholar
PubMed
Search for other papers by John Costello Jr in
Google Scholar
PubMed
Search for other papers by Dennis McDaniel in
Google Scholar
PubMed
Search for other papers by Joanna Klubo-Gwiezdzinska in
Google Scholar
PubMed
Search for other papers by Olexander Larin in
Google Scholar
PubMed
Search for other papers by Victoria Hoperia in
Google Scholar
PubMed
Search for other papers by Kenneth D Burman in
Google Scholar
PubMed
Search for other papers by Lisa Boyle in
Google Scholar
PubMed
Search for other papers by Leonard Wartofsky in
Google Scholar
PubMed
Search for other papers by Vasyl Vasko in
Google Scholar
PubMed
-proliferative effects of metformin on endometrial cancer cells ( Takahashi et al . 2014 ). Metformin is considered as a mitotoxic drug and studies in human cancer cells have demonstrated its inhibitory effect on mitochondrial complex I activity ( Wheaton et al . 2014
Search for other papers by Damien A Leach in
Google Scholar
PubMed
Search for other papers by Sue M Powell in
Google Scholar
PubMed
Search for other papers by Charlotte L Bevan in
Google Scholar
PubMed
perspectives on prostate cancer progression . Current Drug Targets 14 441 – 449 . ( doi:10.2174/1389450111314040005 ) Brasky TM Moysich KB Cohn DE White E 2013 Non-steroidal anti-inflammatory drugs and endometrial cancer risk in the
Search for other papers by Diana Lim in
Google Scholar
PubMed
Cancer Genetics Service, Division of Medical Oncology, National Cancer Centre, Singapore, Singapore
Search for other papers by Joanne Ngeow in
Google Scholar
PubMed
). Increased PARPi sensitivity was demonstrated in cell line studies and xenograft models with PTEN mutation ( Mendes-Pereira et al . 2009 ). There is also clinical evidence that PARPi may have a therapeutic utility in PTEN -deficient endometrial cancer
Search for other papers by Brandi B Knight in
Google Scholar
PubMed
Search for other papers by Gabriela M Oprea-Ilies in
Google Scholar
PubMed
Search for other papers by Arumugam Nagalingam in
Google Scholar
PubMed
Department of Hematology and Medical Oncology, Department of Pathology and Laboratory Medicine, Emory Winship Cancer Institute, Department of Surgery, Department of Medicine, Department of Oncology, Emory University School of Medicine, Atlanta, Georgia 30322, USA
Search for other papers by Lily Yang in
Google Scholar
PubMed
Search for other papers by Cynthia Cohen in
Google Scholar
PubMed
Search for other papers by Neeraj K Saxena in
Google Scholar
PubMed
Search for other papers by Dipali Sharma in
Google Scholar
PubMed
, many laboratories including ours have shown that leptin increases proliferation of breast, endometrial, hepatocellular, and many other cancer cells via multiple signaling pathways including Stat3/ERK/Akt signaling ( Housa et al . 2006 , Sharma et al
Search for other papers by Shu Zhang in
Google Scholar
PubMed
Search for other papers by Ping Lei in
Google Scholar
PubMed
Search for other papers by Xinyi Liu in
Google Scholar
PubMed
Search for other papers by Xiangrong Li in
Google Scholar
PubMed
Search for other papers by Kelcey Walker in
Google Scholar
PubMed
Search for other papers by Leela Kotha in
Google Scholar
PubMed
Search for other papers by Craig Rowlands in
Google Scholar
PubMed
Institute of Biosciences and Technology, Department of Veterinary Physiology and Pharmacology, Dow Chemical Company, Texas A&M Health Science Center, 2121 Holcombe Boulevard, Houston, Texas 77030, USA
Search for other papers by Stephen Safe in
Google Scholar
PubMed
drug target for a number of diseases including ER-positive breast cancer, endometrial, prostate and pancreatic cancer and also for some autoimmune diseases ( McDougal et al . 1997 , 2001 , Castro-Rivera et al . 1999 , Jana et al . 2000 , Wormke
Search for other papers by Theodora S Ross in
Google Scholar
PubMed
‘endometrial or ovarian’ cancer in her 60s and one of his three brothers died of ‘adrenal’ cancer at age 50. Grace's mother was a healthy member of a large Polish Catholic family in which only she and a sister were diagnosed with breast cancers in their late 60
Search for other papers by V Craig Jordan in
Google Scholar
PubMed
cancer and longer adjuvant therapy (5 years) was better than shorter (1–2 years) therapy. Concern about an increased incidence of fatal endometrial cancer was calculated to be manageable. A gynaecological examination before adjuvant tamoxifen therapy
Search for other papers by V Craig Jordan in
Google Scholar
PubMed
tamoxifen trials was consistently at 50% and safety with endometrial cancer in postmenopausal women was much less significant than feared. Also, the concern about tamoxifen-induced rat hepatocarcinogenesis was not translated to human treatment trials. The
Search for other papers by Lamis Yehia in
Google Scholar
PubMed
Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA
Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
Germline High Risk Cancer Focus Group, CASE Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA
Search for other papers by Charis Eng in
Google Scholar
PubMed
prostate, kidney, endometrial, breast and brain cancers ( Li & Sun 1997 , Li et al . 1997 , Risinger et al . 1997 , Steck et al . 1997 ) and considered as one of the most frequently somatically mutated genes in human cancers ( Cantley & Neel 1999
Search for other papers by Xuan Chen in
Google Scholar
PubMed
Search for other papers by Sixuan Liu in
Google Scholar
PubMed
Search for other papers by Xue Peng in
Google Scholar
PubMed
Search for other papers by Xiangyun Zong in
Google Scholar
PubMed
as cervical cancer, endometrial cancer, ovarian epithelial cancer, and breast cancer ( Peluso et al. 2014 , Vaz-Luis & Partridge 2018 ). Therefore, AMH can unexpectedly contribute to the reduction of the growth and metastasis of breast cancer cells